Reuters: FDA approves Dermira's wipe for excessive armpit sweating

2018-06-29 (443 Days Old)Total Views: 91 | Last 7 Days: 4

(Reuters) - Dermira Inc said on Friday its topical cloth for excessive armpit sweating was approved by the U.S. Food and Drug Administration, providing patients with an easy-to-use option for an often embarrassing condition.

Array's melanoma combo treatment wins FDA approval. June 27 (Reuters) - Array BioPharma Inc said on
Wednesday the U.S. Food and Drug Administration approved its
combination treatment for use in patients with the deadliest
form of skin cancer. >>

CORRECTED-Array's melanoma combo treatment wins FDA approval. June 27 (Reuters) - The U.S. Food and Drug Administration
said on Wednesday it had approved Array BioPharma Inc's
combination treatment for use in patients with the deadliest
form of skin cancer. >>

CORRECTED-UPDATE 1-FDA approves Array BioPharma's melanoma combo treatment. June 27 (Reuters) - The U.S. Food and Drug Administration
(FDA) said on Wednesday it had approved Array BioPharma Inc's
oral combination treatment for use in patients with the
deadliest form of skin cancer. >>

FDA agrees to fast-track review of one-dose flu drug. After the worst flu season in nearly a decade, a new drug could revolutionize how we treat the seasonal virus >>

FDA approves Dermira's treatment for excessive armpit sweating. (Reuters) - Dermira Inc said on Friday its treatment for excessive armpit sweating was approved by the U.S. Food and Drug Administration approved, providing patients with an easy-to-use option for an often embarrassing condition. >>

FDA approves Dermira's treatment for excessive armpit.... June 29 (Reuters) - Dermira Inc said on Friday its treatment for excessive armpit sweating was approved by the U.S. Food and Drug Administration approved,... >>

FDA OKs first drug made to reduce excessive sweating. The U.S. Food and Drug Administration has approved the first drug developed specifically to reduce excessive sweating, a common condition that can cause... >>

Single dose flu drug could be here by flu season. It was given a priority review by the FDA. >>

UPDATE 1-FDA approves Array BioPharma's melanoma combo treatment. June 27 (Reuters) - The U.S. Food and Drug Administration
(FDA) said on Wednesday it had approved Array BioPharma Inc's
oral combination treatment for use in patients with the
deadliest form of skin cancer. >>

UPDATE 1-FDA approves Dermira's treatment for excessive armpit sweating. June 29 (Reuters) - Dermira Inc said on Friday its
treatment for excessive armpit sweating was approved by the U.S.
Food and Drug Administration approved, providing patients with
an easy-to-use option for an often embarrassing condition. >>

UPDATE 2-Array BioPharma gets FDA nod for melanoma combo treatment. June 27 (Reuters) - The U.S. Food and Drug Administration
said on Wednesday it approved Array BioPharma Inc's
oral combination treatment for use in patients with the
deadliest form of skin cancer. >>